Lassa Fever Claims 146 Lives as Bauchi, Taraba Lead in Fatalities

Nigeria is currently grappling with an escalating Lassa fever outbreak, marked by a concerning increase in fatalities across various states. Official figures from treatment centres and national surveillance systems reveal both widespread transmission and a growing death toll.

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported over 500 confirmed cases and 146 deaths from Lassa fever since the beginning of the year up to mid-March. The outbreak has also affected at least 38 healthcare workers, with three confirmed deaths among them, a situation experts attribute to occupational exposure and deficiencies in infection prevention protocols.

Data indicates that the case fatality rate (CFR) for the current outbreak has reached 25.1%. This figure is notably higher than the 18.7% recorded during the same period in 2025, suggesting that a larger proportion of infected individuals are succumbing to the illness despite ongoing response measures.

During the most recent reporting week, confirmed cases saw a significant spike, rising from 40 to 66. New infections were identified in Bauchi, Ondo, Taraba, Plateau, Edo, Benue, Kogi, Gombe, and Niger states, pointing to sustained transmission across multiple regions rather than isolated incidents.

Collectively, 21 states and 82 local government areas have registered at least one confirmed case in 2026. This widespread geographic distribution underscores the significant challenge in containing the disease beyond its traditional endemic zones.

Public health professionals have expressed concern over the elevated fatality rate, especially given that Lassa fever is treatable when diagnosed early. This raises questions about systemic issues within diagnosis, referral networks, and access to timely medical care.

Bauchi and Taraba Outbreaks Significantly Impacting National Fatality Figures

The overall national death toll is substantially influenced by severe outbreaks in Bauchi and Taraba states. While the specifics differ, both states highlight systemic weaknesses in the healthcare response.

In Bauchi, Médecins Sans Frontières (MSF) data shows 311 confirmed cases and 68 deaths between October 1, 2025, and March 23, 2026. This translates to a case fatality rate of approximately 21.9%, slightly below the national average but still high for a disease with established treatment protocols.

MSF, which has been providing support for Lassa fever treatment in Bauchi since 2022, is expanding its interventions in early diagnosis, treatment, and community engagement. Their operations are focused in the local government areas of Bauchi, Kirfi, Toro, and Tafawa Balewa.

Dr. Ayokunnu Raji, Emergency Programme Manager, noted that the similar symptoms between Lassa fever and malaria frequently lead to delayed diagnosis, as many patients are initially treated for more common febrile illnesses.

Abdulkareem Yakubu, an MSF official, identified misinformation and delayed health-seeking behaviours as persistent challenges. He emphasized that the organization is not only treating patients but also working to combat misinformation and enhance the capabilities of local healthcare providers, stressing the critical importance of early presentation at healthcare facilities.

In Taraba State, the outbreak appears to be more critical. The Federal Medical Centre (FMC) in Jalingo reported 50 deaths out of 95 confirmed cases, resulting in a case fatality rate exceeding 52%. This rate is more than double the national average and is among the highest recorded at a facility level in recent outbreaks.

Dr. Suleiman Abubakar Kirim, Head of Clinical Services at FMC Jalingo, described the situation as the most severe the hospital has faced in years. He attributed the high mortality predominantly to patients presenting their illness at advanced stages.

"Many patients arrive at the hospital when the disease has already progressed significantly. At such a point, even with treatment, the outcomes are often poor," he stated.

Out of 226 suspected cases managed at the Jalingo facility, 20 patients have recovered and been discharged. However, new infections continue to be reported.

Health officials observe that severe cases frequently present with serious complications, including bleeding, respiratory distress, and organ failure. These complications drastically increase the risk of mortality, particularly in areas with limited access to intensive care support, which may partly explain the stark contrast in fatality rates between Taraba and the national average.

Beyond Bauchi and Taraba, traditionally endemic states like Plateau, Edo, Benue, Kogi, Gombe, Ondo, and Niger continue to report substantial numbers of cases annually. Recent trends, however, suggest a growing disease burden in parts of northern Nigeria.

Epidemiological data consistently shows that a few states contribute disproportionately to the overall infection figures, with Ondo, Edo, and Bauchi regularly listed among the highest contributors, indicating persistent transmission hotspots.

Health System Deficiencies Exacerbate Outcomes

Public health experts have indicated that the rising fatality rate is a reflection of deeper structural issues within Nigeria's healthcare system.

A senior doctor from Kubwa General Hospital in Abuja, who wished to remain anonymous, highlighted that the current data indicates a persistent problem with early case detection. He remarked, "What we are observing is not only an increase in cases but also an increase in late-stage presentations. Lassa fever is highly treatable if identified early, but once complications arise, the risk of death escalates considerably."

He further noted that many primary healthcare centres lack the necessary capacity to suspect or confirm Lassa fever in its initial stages. "Frontline facilities are still not adequately equipped to differentiate Lassa fever from malaria or typhoid. This is where the problem originates," he added.

Dr. Hammed Alausa, another physician, pointed out that weak referral systems are worsening the situation. "Patients often move between facilities before receiving a correct diagnosis. By the time they reach a treatment centre, critical time has been lost," Alausa explained.

He also highlighted the issue of uneven distribution of treatment centres across the country. "Access is a significant problem. In many instances, patients must travel long distances while critically ill. That delay can prove fatal," he commented.

Challenges within the health system are further complicated by issues with infection prevention within healthcare facilities. Management at FMC Jalingo emphasized the importance of proper consumables in reducing transmission risks.

"The absence of properly structured and sterile consumables increases the risk of transmission to healthcare workers and other patients," the hospital stated.

According to Alausa, such risks are not unique to Taraba. "Infection prevention and control practices remain inconsistent across facilities. Protecting health workers is paramount, as their exposure further weakens the response system," he stated.

The infection of at least 38 healthcare workers underscores these systemic gaps, with exposures often linked to delayed case recognition, insufficient protective gear, and high-risk interventions.

Community Risks, Shifting Patterns, and Response Deficiencies

At the community level, transmission is continuously influenced by environmental and behavioural factors, particularly during the dry season when rodents, the primary carriers of the virus, seek food indoors.

Dr. Chukwudi Ifeanyi, another physician, identified a significant gap in public awareness. "Many people still do not understand how Lassa fever is transmitted. Basic preventive measures, such as proper food storage and waste management, are not widely adopted," he said.

He also mentioned that misinformation often leads to delayed seeking of medical attention. "Some patients resort to self-medication or traditional remedies before seeking hospital care, and this delay can be deadly," he warned.

Experts also suggest a potential geographical shift in Lassa fever transmission patterns. While southern states like Ondo and Edo have long been recognised as epicentres, the growing burden in northern states such as Bauchi and Taraba indicates evolving dynamics.

Dr. Ifeanyi speculated that this shift might be related to environmental and demographic influences. "We might be observing the effects of climate variability, population movement, and improved detection in previously underreported regions. However, regardless of the cause, the response system must adapt swiftly," he advised.

To mitigate fatalities, experts have called for prompt improvements across various levels of the health system. Key recommendations include enhancing rapid diagnostic capabilities at primary healthcare centres, reinforcing referral networks, and expanding treatment facilities to underserved areas.

Dr. Alausa stressed the necessity of investing in early detection. "If we can diagnose cases earlier at the community level, we will significantly reduce mortality. That is where the greatest impact lies," he asserted.

While underscoring the importance of community involvement, he added, "Prevention begins at the household level. People need to understand the risks and take practical steps to safeguard themselves."

Furthermore, he highlighted the need to bolster surveillance systems and improve real-time data reporting to facilitate a more rapid response to outbreaks.

Although the onset of the rainy season might temporarily reduce transmission, experts caution that seasonal changes alone are insufficient. Resident doctor Godwin Ekweke warned that without systemic improvements, the country will continue to experience recurring outbreaks with high fatality rates.

"We cannot solely depend on seasonal decline. Without strengthening our systems, we will continue to face the same challenge year after year," he stated.

With 146 deaths recorded nationally within the reporting period, in addition to 68 in Bauchi and 50 in Taraba, the latest figures not only highlight the scale of the outbreak but also the disparity in survival outcomes among states.

For many experts, the core message is evident: reducing Lassa fever deaths will depend more on how quickly Nigeria can bridge the gap between diagnosis and treatment, rather than on seasonal fluctuations. Until these systemic improvements are made, the data suggests that Nigeria's struggle against the disease is far from over.